CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF MEDICAL OFFICER sold 12,000 shares at an average $15.94 ($191,339)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $15.92 ($318,334)
- 144 Insider Sale of Securities
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Planned sale PRESIDENT & CSO sold 50,000 shares at $14.20 ($710,195)
- 144 Insider Sale of Securities
- 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $11.15 ($223,036)
- 144 Insider Sale of Securities
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 4,400 shares at $11.31 ($49,771)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Grant or award SVP, FINANCE AND CAO acquired 15,000 shares (grant or award)
Page 9 of 22 · 421 filings